Systems analysis of drug-induced receptor tyrosine kinase reprogramming following targeted mono- and combination anti-cancer therapy
Goltsov, Alexey, Deeni, Yusuf, Khalil, Hilal S, Soininen, Tero, Kyriakidis, Stylianos, Hu, Huizhong, Langdon, Simon P, Harrison, David J, Bown, James
Published in Cells (Basel, Switzerland) (10.06.2014)
Published in Cells (Basel, Switzerland) (10.06.2014)
Get full text
Journal Article
A novel mechanism of action of HER2 targeted immunotherapy is explained by inhibition of NRF2 function in ovarian cancer cells
Khalil, Hilal S, Langdon, Simon P, Goltsov, Alexey, Soininen, Tero, Harrison, David J, Bown, James, Deeni, Yusuf Y
Published in Oncotarget (15.11.2016)
Published in Oncotarget (15.11.2016)
Get full text
Journal Article
The targeting of epidermal growth factor family receptors (ERBBs) in ovarian cancer therapy
Deeni, Yusuf, Khalil, Hilal, Goltsov, Alexey, Soininen, Tero, Langdon, Simon, Harrison, David, Bown, James
Published in Journal of biotechnology (20.08.2015)
Published in Journal of biotechnology (20.08.2015)
Get full text
Journal Article